Ticagrelor for patients with acute coronary syndromes: PLATOnic affair or lasting SWEDEHEART?
Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA.|Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark.
Manan
M
Pareek
Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA dlbhattmd@post.harvard.edu.
Deepak L
DL
Bhatt
D054058:Acute Coronary Syndrome; D000241:Adenosine / Q000031:analogs & derivatives; D006801:Humans; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D013988:Ticlopidine
D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine